Aspirin-free antithrombotic management following coronary stenting. Myth or reality?
ABSTRACT The use of aspirin in combination with a P2Y12 receptor inhibitor, also known as dual antiplatelet therapy, is at the cornerstone of treatment for patients undergoing coronary stenting. The use of newer generation P2Y12 inhibitors (ie, prasugrel and ticagrelor), characterized by more potent...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2019-02-01
|
| Series: | REC: Interventional Cardiology (English Ed.) |
| Subjects: | |
| Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=108 |